| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A combination of routine laboratory findings and vital signs can predict survival of advanced cancer patients without physician evaluation: a fractional polynomial model
|
Hamano, Jun
|
|
2018
|
105 |
C |
p. 50-60
|
artikel
|
| 2 |
Author response to comment on ‘significance of extranodal tumour deposits in colorectal cancer: A systematic review and meta-analysis’
|
Lord, Amy C.
|
|
2018
|
105 |
C |
p. 129-130
|
artikel
|
| 3 |
Cancers related to lifestyle and environmental factors in France in 2015
|
Soerjomataram, Isabelle
|
|
2018
|
105 |
C |
p. 103-113
|
artikel
|
| 4 |
Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study
|
Namikawa, Kenjiro
|
|
2018
|
105 |
C |
p. 114-126
|
artikel
|
| 5 |
Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres
|
Callegaro, Dario
|
|
2018
|
105 |
C |
p. 19-27
|
artikel
|
| 6 |
Liquid biopsy: a new diagnostic, predictive and prognostic window in cancers of unknown primary
|
El Rassy, Elie
|
|
2018
|
105 |
C |
p. 28-32
|
artikel
|
| 7 |
Mental disorders associated with recent cancer diagnosis: Results from a nationally representative survey
|
Mallet, Jasmina
|
|
2018
|
105 |
C |
p. 10-18
|
artikel
|
| 8 |
Opioid responsiveness of nociceptive versus mixed pain in clinical cancer patients
|
Bechakra, Malik
|
|
2018
|
105 |
C |
p. 79-87
|
artikel
|
| 9 |
Re-evaluation of HER2 status in patients with HER2-positive advanced or recurrent gastric cancer refractory to trastuzumab (KSCC1604)
|
Saeki, Hiroshi
|
|
2018
|
105 |
C |
p. 41-49
|
artikel
|
| 10 |
Rheumatic immune-related adverse events secondary to anti–programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series
|
Mitchell, Emma L.
|
|
2018
|
105 |
C |
p. 88-102
|
artikel
|
| 11 |
Safety profile of subcutaneous trastuzumab for the treatment of patients with HER2-positive early or locally advanced breast cancer: primary analysis of the SCHEARLY study
|
Zambetti, Milvia
|
|
2018
|
105 |
C |
p. 61-70
|
artikel
|
| 12 |
Sorafenib as first-line therapy in patients with advanced Child-Pugh B hepatocellular carcinoma—a meta-analysis
|
McNamara, Mairéad Geraldine
|
|
2018
|
105 |
C |
p. 1-9
|
artikel
|
| 13 |
Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trial
|
Chen, Li-Tzong
|
|
2018
|
105 |
C |
p. 71-78
|
artikel
|
| 14 |
Tumor deposit versus extra nodal extension: a differential evaluation of prognostic relevance
|
Chen, Hao
|
|
2018
|
105 |
C |
p. 127-128
|
artikel
|
| 15 |
Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort
|
Kandel, M.
|
|
2018
|
105 |
C |
p. 33-40
|
artikel
|
Tijdschrift beschrijving